Aspen Neuroscience is dedicated to developing and delivering iPSC-derived autologous cell replacement therapies for patients with high unmet medical need, beginning with Parkinson…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
Aspen Neuroscience is dedicated to developing and delivering iPSC-derived autologous cell replacement therapies for patients with high unmet medical need, beginning with Parkinson…
Avilar Therapeutics is pioneering the discovery and development of extracellular protein degraders, focusing on a new class of therapeutics called ATACs (ASGPR Targeting Chimeras)…
ClicBio is revolutionizing the treatment of metabolic diseases by targeting the hunger pathway with a groundbreaking mechanism that acts as a pivotal molecular switch, regulating…
GC Therapeutics (GCTx) is harnessing the world’s first “plug-and-play” induced pluripotent stem cell (iPSC) cellular programming platform, TFome™, to overcome the development and…
Immunitas is committed to discovering and developing novel, differentiated therapeutics for patients with cancer and autoimmune diseases. Our lead program, IMT-009, targets CD161…
Synaptiq Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing therapies for co-morbid neuropsychiatric disorders. The company is advancing SYN-001 fo…
Pleno is enabling AI-driven precision medicine at scale with faster, lower-cost, higher-plex multiomics through its RAPTOR instrument platform, which is designed for medium to hig…
ProJenX is a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically defined pathways for the treatment of amyotrophic lateral scle…
SonoThera is dedicated to developing the next generation of genetic medicines using a proprietary, non-invasive ultrasound-mediated delivery approach that enables broad, highly ta…
Trotana Therapeutics develops novel oral anti-inflammatory medicines, focusing on addressing significant unmet needs in chronic inflammatory diseases. The company leverages advanc…
Truvian is a transformational healthcare company bringing lab-accurate results anywhere you go, enabling patients to engage healthcare providers to lead healthier lives. With a fo…
TwoStep Therapeutics is a biotech company developing new targeted therapeutics for solid tumors, focusing on targeted cytotoxic drug delivery and immunotherapy.
Ladder Bio is a therapeutics company developing Spiroligomer™ ladder-shaped peptide-like molecules—sequence-defined, structurally preorganized molecules designed to be orally avai…